Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Petukhova, J. Krasnova, A. Dzizinskii (Irkutsk, Russian Federation). Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease. Eur Respir J 2008; 32: Suppl. 52, 492

Member's Comments

Andrey Vasnev - 04.10.2008 13:05
From Vasnev A (see P508)
Yulia, very simple and good work with essential results! Our work is quite concordant to yours and add much new to the pathophisiology of COPD. In one of our work (P508)we have shown that COPD was accompanied with a low grade blood flow centralization through the increased systemic overexpression of alpha 1 adrenoreceptors. Salmeterol is one of the beta 2 agonist which induces it. In general I dont support the idia of using beta 2 agonist in COPD. Moreover I think that beta 2 agonists as well as beta blokers (especially selective) are jatrogenic cause of COPD but we wont say this awful thing to anybody. You understand.

Related content which might interest you: Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006 Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Efficacy and safety of salmeterol in patients with bronchial asthma (BA) and ischemic heart disease (IHD) Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Underestimation of bronchial obstruction in patients with coronary heart disease and cardiac insufficiency Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Underappreciation of coronary artery disease in patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006 Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Blood pressure and heart rate variability response to noninvasive ventilation in patients with exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007 Reduced heart rate variability in chronic bronchial asthma with steroid dependency Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004 Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)> Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014